Clinical Trial Update: Conversion Therapy of RAS/BRAF Wild-Type Colorectal Cancer Patients With Initially Unresectable Liver Metastases [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating conversion therapy for RAS/BRAF wild-type colorectal cancer patients with initially unresectable liver metastases; currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Fudan University | Conditions: Colorectal Cancer, Liver Metastases | Phase 3 | Status: RECRUITING